‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.
Opioid treatment receives $377m funding increase The measure, included in this week’s Federal Budget, will ‘save lives’, according to the RACGP President.
Codeine use down by 37% since up-scheduling Use of the drug has dropped substantially across all jurisdictions, a new wastewater-based epidemiology report suggests.
TGA flags possible amendments to paracetamol Poisons Standard Wider consultation is being sought on amending current access controls, following a review into the risks of intentional self-poisoning.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
New online benzodiazepine hub hopes to reduce harms The resources provide guidance and support for the management of benzodiazepine dependence and misuse in primary care.
Providing help that is needed but not wanted Dr Thileepan Naren’s choice to persevere with a patient during their recovery from opioid addiction led to triumphant outcomes.
How can opioid deaths be reduced? New studies further verify the benefits of pharmacotherapy for opioid dependence in greatly reducing all-cause mortality rates.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.